Form 4: Ensign Group Director Ann Scott Blouin Acquires Shares

Director Ann Scott Blouin acquired 600 shares of Ensign Group, Inc. (ENSG) common stock on April 15, 2026.

Summary

• Director Ann Scott Blouin was granted 600 shares of common stock in The Ensign Group, Inc.
• The transaction occurred on April 15, 2026.
• The shares were acquired at a price of $0, representing a stock-based compensation grant.
• Following this transaction, the director's total beneficial ownership is 23,452 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial health.

Positives

• Increased equity alignment between the director and shareholders.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The shares vest in three equal annual installments beginning April 15, 2027.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices designed to align board member interests with long-term shareholder value in the healthcare services sector.

Comparison to Industry Standards

• The grant of equity to non-employee directors is consistent with standard compensation practices for publicly traded healthcare companies like Ensign Group.

Stakeholder Impact

• Minor increase in director equity stake, reinforcing long-term commitment to the company.

Next Steps

• Vesting of the 600 shares in three equal annual installments starting April 15, 2027.

Key Dates

Keywords

ENSG, Ensign Group, Form 4, Insider Trading, Director Ownership